Sol-Gel to receive upfront and regulatory milestone payments totaling in up to low 7-digit USD and either fixed transfer sale price or low double-digit royalties from net sales; payments are ...

Sample preparation and sol–gel transition. The temperature-responsive sol–gel transition behavior of the copolymer solution or suspension was investigated by the test-tube inversion method. 10 ...

After the wetting, the build-up of the porous network takes place through gel formation, yielding thicknesses of 50-500 nm. Thicker layers, suitable as membranes for example, are created by repeated ...

Sol-Gel to receive $16 million during 2025Cash runway is expected to extend into the first quarter of 2027; Company expects to have sufficient cash to complete its Phase III clinical trialSGT-610 ...

Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a clinical-stage dermatology company, and Galderma, the world’s largest independent dermatology company, to ...

Sol-Gel is collaborating with Perrigo Co. PLC for developing a couple of generic products. A generic version of Zovirax cream, 5%, used to treat cold sores, ...

Figure 4. TG-DTA analysis of the synthesized Ru doped TiO 2 nanoparticles by combination a sol-gel process and a hydrothermal process.. Conclusions. Ru doped TiO 2 particles have been synthesized by a ...

Sol-Gel’s technology was developed at the Hebrew University of Jerusalem. It has a combination of 13 patents and patent applications that were either developed by the company or licensed from Yissum ...

--Sol-Gel Technologies Ltd., a clinical-stage dermatology company, today announced a reverse share split of the Company’ s issued and outstanding ordinary shares, par value NIS 0.1 per share, at ...